CMTM3 inhibits cell migration and invasion and correlates with favorable prognosis in gastric cancer

Cancer Science

Volumn 105, Issue 1, 2014, Pages 26-34

  Su, Yu ^a,b   Lin, Yi ^c,d   Zhang, Lianhai ^c   Liu, Baocai ^a,b   Yuan, Wanqiong ^a,b   Mo, Xiaoning ^a,b   Wang, Xiaohong ^c   Li, Henan ^a,b   Xing, Xiaofang ^c   Cheng, Xiaojing ^c   Dong, Bin ^c   Hu, Ying ^c   Du, Hong ^c   Zhu, Yubing ^c   Ding, Ning ^c   Li, Jiyou ^c   Liu, Weili ^a,b   Ma, Yongzhen ^a,b,e   Qiu, Xiaoyan ^a,b   Ji, Jiafu ^c   Han, Wenling ^a,b   more..

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b BEIJING HOSPITAL   (China)

^c PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e Shandong Medical College   (China)

Author keywords

CMTM3; Gastric cancer; MARVEL; Survival; Tumor suppressor gene

Indexed keywords

CMTM3 PROTEIN; GELATINASE A; KRUPPEL LIKE FACTOR 5; MARVEL DOMAIN CONTAINING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DISSEMINATED CANCER; DOWN REGULATION; ENZYME PHOSPHORYLATION; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; GENETIC REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIGRATION INHIBITION; MOUSE; NONHUMAN; PATIENT; PERITONEUM METASTASIS; PRIORITY JOURNAL; SEX DIFFERENCE; STOMACH CANCER; STOMACH MUCOSA; TUMOR SUPPRESSOR GENE; VERY ELDERLY; YOUNG ADULT;

CMTM3; GASTRIC CANCER; MARVEL; SURVIVAL; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINES; COHORT STUDIES; DOWN-REGULATION; FEMALE; GASTRIC MUCOSA; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MARVEL DOMAIN-CONTAINING PROTEINS; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PROGNOSIS; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 84892877028     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12304     Document Type: Article

References (30)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Jankowski JA, Odze RD. Biomarkers in gastroenterology: between hope and hype comes histopathology. Am J Gastroenterol 2009; 104: 1093-6.
3. Han W, Ding P, Xu M et al. Identification of eight genes encoding chemokine-like factor superfamily members 1-8 (CKLFSF1-8) by in silico cloning and experimental validation. Genomics 2003; 81: 609-17.
4. Shao L, Li T, Mo X et al. Expressional and functional studies of CKLF1 during dendritic cell maturation. Cell Immunol 2010; 263: 188-95.
5. Wang Y, Li T, Qiu X et al. CMTM3 can affect the transcription activity of androgen receptor and inhibit the expression level of PSA in LNCaP cells. Biochem Biophys Res Commun 2008; 371: 54-8.
6. Wang Y, Li J, Cui Y et al. CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis. Cancer Res 2009; 69: 5194-201.
7. Song HS, Shi S, Lu XZ et al. Intracellular CMTM2 negatively regulates human immunodeficiency virus type-1 transcription through targeting the transcription factors AP-1 and CREB. Chin Med J (Engl) 2010; 123: 2440-5.
8. Plate M, Li T, Wang Y et al. Identification and characterization of CMTM4, a novel gene with inhibitory effects on HeLa cell growth through Inducing G2/M phase accumulation. Mol Cells 2010; 29: 355-61.
9. Niu J, Li H, Zhang Y et al. Aberrant expression of CKLF-like MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemia. Leuk Res 2011; 35: 771-6.
10. Zhang W, Mendoza MC, Pei X et al. Down-regulation of CMTM8 induces epithelial-to-mesenchymal transition-like changes via c-MET/extracellular signal-regulated kinase (ERK) signaling. J Biol Chem 2012; 287: 11850-8.
11. Lind GE, Ahlquist T, Kolberg M et al. Hypermethylated MAL gene - a silent marker of early colon tumorigenesis. J Transl Med 2008; 6: 13.
12. Buffart TE, Overmeer RM, Steenbergen RD et al. MAL promoter hypermethylation as a novel prognostic marker in gastric cancer. Br J Cancer 2008; 99: 1802-7.
13. Shao L, Cui Y, Li H et al. CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines. Clin Cancer Res 2007; 13: 5756-62.
14. Ajani JA, Barthel JS, Bekaii-Saab T et al. Gastric cancer. J Natl Compr Canc Netw 2010; 8: 378-409.
15. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 3rd English edition. Gastric Cancer 2011; 14: 101-12.
16. Li Z, Zhan W, Wang Z et al. Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasis. Biochem Biophys Res Commun 2006; 348: 229-37.
17. Carvajal-Carmona LG, Cazier JB, Jones AM et al. Fine-mapping of colorectal cancer susceptibility loci at 8q23.3, 16q22.1 and 19q13.11: refinement of association signals and use of in silico analysis to suggest functional variation and unexpected candidate target genes. Hum Mol Genet 2011; 20: 2879-88.
18. Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003; 3: 362-74.
19. Li X, Cheung KF, Ma X et al. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients. Oncogene 2012; 31: 3419-30.
20. Hou Q, Wu YH, Grabsch H et al. Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer. Cancer Res 2008; 68: 4623-30.
21. Cervantes A, Rosello S, Roda D, Rodriguez-Braun E. The treatment of advanced gastric cancer: current strategies and future perspectives. Ann Oncol 2008; 19(Suppl 5): v103-7.
22. Hsu PI, Hsieh HL, Lee J et al. Loss of RUNX3 expression correlates with differentiation, nodal metastasis, and poor prognosis of gastric cancer. Ann Surg Oncol 2009; 16: 1686-94.
23. Matsuoka J, Yashiro M, Sakurai K et al. Role of the stemness factors sox2, oct3/4, and nanog in gastric carcinoma. J Surg Res 2012; 174: 130-5.
24. Warneke VS, Behrens HM, Hartmann JT et al. Cohort study based on the seventh edition of the TNM classification for gastric cancer: proposal of a new staging system. J Clin Oncol 2011; 29: 2364-71.
25. Kominea A, Konstantinopoulos PA, Kapranos N et al. Androgen receptor (AR) expression is an independent unfavorable prognostic factor in gastric cancer. J Cancer Res Clin Oncol 2004; 130: 253-8.
26. Freedman ND, Ahn J, Hou L et al. Polymorphisms in estrogen- and androgen-metabolizing genes and the risk of gastric cancer. Carcinogenesis 2009; 30: 71-7.
27. Zhang Y, Wang R, Song H et al. Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer. Cancer Lett 2011; 303: 21-8.
28. Raleigh DR, Marchiando AM, Zhang Y et al. Tight junction-associated MARVEL proteins marveld3, tricellulin, and occludin have distinct but overlapping functions. Mol Biol Cell 2010; 21: 1200-13.
29. Mariano C, Sasaki H, Brites D, Brito MA. A look at tricellulin and its role in tight junction formation and maintenance. Eur J Cell Biol 2011; 90: 787-96.
30. Kojima T, Takasawa A, Kyuno D et al. Downregulation of tight junction-associated MARVEL protein marvelD3 during epithelial-mesenchymal transition in human pancreatic cancer cells. Exp Cell Res 2011; 317: 2288-98.